Quantcast

Latest Human respiratory syncytial virus Stories

2014-09-30 08:32:38

Acquisition Strengthens Existing Pipeline in Viral Diseases NEW BRUNSWICK, N.J., Sept. 30, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced a definitive agreement to acquire Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash. The acquisition will include Alios BioPharma's portfolio of potential therapeutics for viral infections including...

2014-09-24 16:26:27

ReportsnReports.com offers Bronchopulmonary Dysplasia - Pipeline Review, H2 2014 and Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2014 new market reports. These reports provide an overview of the Bronchopulmonary Dysplasia's and Respiratory Syncytial Virus (RSV) Infections therapeutic pipeline. DALLAS, Sept. 24, 2014 /PRNewswire-iReach/ -- These reports provide comprehensive information on the therapeutic development for Bronchopulmonary Dysplasia and Respiratory...

2014-09-18 08:29:39

MILFORD, Mass., Sept. 18, 2014 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of RNA viruses, today announced a research collaboration with the National Institutes of Health (NIH) for animal testing of the Company's lead compound, SB 9200, against multiple viral pathogens, classified as "Special Pathogens," against which currently there are no effective antiviral therapies. SB 9200, derived...

2014-09-02 08:28:48

Redundant targets extend coverage to provide detection of seasonal and emerging novel viruses SUNNYVALE, Calif., Sept. 2, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) announced today the release of Xpert(® )Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination of Flu A, Flu B, and differentiation of RSV infection. The test will be marketed as a CE-IVD product under the European Directive on In Vitro Diagnostic Medical Devices, bringing the total number of...

2014-05-23 23:11:02

WebsiteAlive, a Houston-based online communications firm best known for its AliveChat online chat product, sponsored a team of triathletes for the 2014 Ironman Texas, held May 17, in The Woodlands, Texas. The team was raising money to fund research into RSV, a respiratory disease that kills newborns. Houston, Texas (PRWEB) May 23, 2014 On May 17, a team of five athletes from the Houston gym NonameFit competed in Ironman Texas, an endurance triathlon in The Woodlands, Texas, consisting of...

Two Separate Studies On MERS-Coronavirus Offer Better Understanding Of Newly Emerging Disease
2014-04-29 09:33:16

Lawrence LeBlond for redOrbit.com - Your Universe Online Two separate studies this week are helping scientists gain a better understanding of the dangerous Middle East respiratory syndrome (MERS) coronavirus, a disease that has sickened more than 300 people and left at least a hundred dead since it was first reported in September 2012. HUMAN ANTIBODIES The first study comes from scientists at Dana-Farber Cancer Institute who have identified natural human antibodies against the virus...

2014-04-24 23:00:33

Dr. Richard Plemper, a professor in the new Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.83 million federal grant to develop novel therapeutics against Respiratory Syncytial Virus (RSV) infection. Atlanta, GA (PRWEB) April 25, 2014 Dr. Richard Plemper, a professor in the new Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.83 million federal grant to develop novel therapeutics against Respiratory...

2014-04-21 23:02:00

Ginseng can help treat and prevent influenza and respiratory syncytial virus (RSV), a respiratory virus that infects the lungs and breathing passages, according to research findings by a scientist in Georgia State University’s new Institute for Biomedical Sciences. Atlanta, Georgia (PRWEB) April 21, 2014 Ginseng can help treat and prevent influenza and respiratory syncytial virus (RSV), a respiratory virus that infects the lungs and breathing passages, according to research findings by...

2014-04-18 12:35:28

A Dana-Farber/Boston Children's and VA Hospital/University of South Florida team created the antiviral therapy, which harnesses the power of stapled peptide and nanoparticle technologies to thwart the respiratory virus New therapies are needed to prevent and treat respiratory syncytial virus (RSV) – a potentially lethal respiratory infection that can severely affect infants, young children and the elderly. Despite a wide range of anti-RSV efforts, there are no vaccines or drugs on the...

2014-04-15 04:20:50

LONDON, April 15, 2014 /PRNewswire/ -- reViral, an antiviral drug discovery and development company, focused on diseases caused by the respiratory syncytial virus (RSV), today announced the appointment of Professor Raymond Schinazi to its Board as a Non-Executive Director, effective from 9 April 2014. Professor Schinazi has had a long and prestigious career in the industry having founded several successful biotechnology companies including Pharmasset, where he chaired...


Latest Human respiratory syncytial virus Reference Libraries

45_372e8ab43ffc45ec313edc65d2ef1af0
2011-02-23 17:56:27

Respiratory syncytial virus (RSV) causes respiratory tract infections and is a major cause of lower respiratory tract infection and hospital visits during infancy and childhood. For premature infants and infants with congenital heart disease there is a prophylactic medication. During winter months in temperate climates there is an annual epidemic. Infection in tropical climates is most common during the rainy season. 60% of infants, in the United States, are infected during their first...

More Articles (1 articles) »
Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.